200 participants
Anlotinib for Hepatocellular Carcinoma
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2021-07-08
- Start Date:
- 2021-06-30
- Completion:
- 2023-07-05
Conditions
- Liver Neoplasms
Interventions
- DRUG
No Results Yet